Natera executive chairman Matthew Rabinowitz sold 102,000 shares at prices from $328.09 to $351.25 across 29 transactions. For investors, the reported ownership outcome is that his Natera holding fell to zero, representing about 100.0% of his prior shares holding.
Key Highlights
- The transactions took place on 14 September 2026 and 15 September 2026.
- All 29 transactions used code S.
- The reported sale represented about 100.0% of Matthew Rabinowitz’s prior shares holding.
Natera, Inc. (NASDAQ: NTRA) executive chairman Matthew Rabinowitz sold 102,000 shares. The transactions left Rabinowitz with 0 shares of Natera, Inc. representing about 100.0% of his prior shares holding.
Rabinowitz completed the sales through 29 separate transactions on 14 September 2026 and 15 September 2026. Each transaction carried code S. Prices ranged from $328.09 to $351.25 per share across the entries. The transaction information identifies Rabinowitz as Natera’s executive chairman. The combined entries account for the reported sale of 102,000 Natera shares.
FAQs
Q: How many Natera shares did Matthew Rabinowitz sell?
A: The filing states that Natera executive chairman Matthew Rabinowitz sold 102,000 shares. It reports that the sales occurred across 29 separate transactions between September 14 and September 15, 2026.
Q: What price range applied to Matthew Rabinowitz’s Natera share sales?
A: The Natera insider transactions were completed at prices ranging from $328.09 to $351.25 per share. The range covers all reported sales.
Q: How many Natera shares did Rabinowitz own after the transactions?
A: Matthew Rabinowitz’s reported Natera holding fell to 0 shares after the transactions. The sold amount represented about 100.0% of his prior shares holding.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.